← Back to headlines
MiNK Therapeutics Stock Surges on Pediatric Cancer Collaboration
MiNK Therapeutics' stock rocketed 60% following the announcement of a new collaboration with C-Further aimed at developing treatments for pediatric cancers.
10 Mar, 10:49 — 10 Mar, 10:49
Sources
Showing 1 of 1 sources
